Early Observations on the Use of Riociguat in a Large, Metropolitan Pulmonary Arterial Hypertension/Chronic Thromboembolic Pulmonary Hypertension Treatment Center

por Sulica, Roxana, Fenton, Rebecca, Cefali, Frank
Publicado 2015

Advances in the management of pulmonary arterial hypertension

por Deshwal, Himanshu, Weinstein, Tatiana, Sulica, Roxana
Publicado 2021

Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies

por Fein, Daniel G., Zaidi, Ali N., Sulica, Roxana
Publicado 2016

Clinical and hemodynamic benefit of macitentan and riociguat upfront combination in patients with pulmonary arterial hypertension

por Sulica, Roxana, Sangli, Swathi, Chakravarti, Aloke, Steiger, David
Publicado 2019

COVID-19 in Pulmonary Artery Hypertension (PAH) Patients: Observations from a Large PAH Center in New York City

por Sulica, Roxana, Cefali, Frank, Motschwiller, Caroline, Fenton, Rebecca, Barroso, Anabela, Sterman, Daniel
Publicado 2021

Long-term impact of add-on sequential triple combination therapy in pulmonary arterial hypertension: real world experience

por Deshwal, Himanshu, Weinstein, Tatiana, Salyer, Rachel, Thompson, Jesse, Cefali, Frank, Fenton, Rebecca, Bondarsky, Eric, Sulica, Roxana
Publicado 2023

Successfully Treated Calcific Uremic Arteriolopathy: Two Cases of a High Anion Gap Metabolic Acidosis with Intravenous Sodium Thiosulfate

por Rein, Joshua L., Miyata, Kana N., Dadzie, Kobena A., Gruber, Steven J., Sulica, Roxana, Winchester, James F.
Publicado 2014

Cor Pulmonale from Concomitant Human Immunodeficiency Virus Infection and Methamphetamine Use

por Maidman, Samuel D., Sulica, Roxana, Freedberg, Robin S., Bamira, Daniel, Vainrib, Alan F., Ro, Richard, Latson, Larry A., Saric, Muhamed
Publicado 2021

A multicenter, retrospective study of patients with pulmonary arterial hypertension transitioned from parenteral prostacyclin therapy to inhaled iloprost

por Channick, Richard N., Frantz, Robert P., Kawut, Steven M., Palevsky, Harold, Tumuluri, Ramagopal, Sulica, Roxana, Lauto, Paula O., Benton, Wade W., de Boisblanc, Bennett
Publicado 2013

Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat

por Rahaghi, Franck F., Balasubramanian, Vijay P., Bourge, Robert C., Burger, Charles D., Chakinala, Murali M., Eggert, Michael S., Elwing, Jean M., Feldman, Jeremy, King, Christopher, Klinger, James R., Mathai, Stephen C., McConnell, John Wesley, Palevsky, Harold I., Restrepo‐Jaramillo, Ricardo, Safdar, Zeenat, Sager, Jeffrey S., Sood, Namita, Sulica, Roxana, White, R. James, Hill, Nicholas S.
Publicado 2022